HALL BRETT MATTHEW (Chief Scientific Officer) purchased 0.6% of their position (2.30K shares) of IMMUNEERING CORP on the open market
Open‑market purchase worth $10.5K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/16/2026ACC: 0001790340-26-000012
Officer· Chief Scientific Officer
Since Jul 2021
+2.30K
Net shares
Net buyer
$10.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.30K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+2.30K
Price / share
$4.57
Trade value
$10.50K
% of position
0.6%
1/15/2026
374.20K→376.50K
Total
Net shares
+2.30K
Net value
$10.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 1/15/2026 | P · Purchase | +2.30K | $4.57 | $10.50K | 0.6% | 374.20K | 376.50K |
| Total | +2.30K | $10.50K | ||||||
Derivative Transactions0
No derivative transactions reported